Literature DB >> 20409489

Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide.

Ann-Christin Brorsson1, Benedetta Bolognesi, Gian Gaetano Tartaglia, Sarah L Shammas, Giorgio Favrin, Ian Watson, David A Lomas, Fabrizio Chiti, Michele Vendruscolo, Christopher M Dobson, Damian C Crowther, Leila M Luheshi.   

Abstract

The extent to which proteins aggregate into distinct structures ranging from prefibrillar oligomers to amyloid fibrils is key to the pathogenesis of many age-related degenerative diseases. We describe here for the Alzheimer's disease-related amyloid beta peptide (Abeta) an investigation of the sequence-based determinants of the balance between the formation of prefibrillar aggregates and amyloid fibrils. We show that by introducing single-point mutations, it is possible to convert the normally harmless Abeta40 peptide into a pathogenic species by increasing its relative propensity to form prefibrillar but not fibrillar aggregates, and, conversely, to abolish the pathogenicity of the highly neurotoxic E22G Abeta42 peptide by reducing its relative propensity to form prefibrillar species rather than mature fibrillar ones. This observation can be rationalized by the demonstration that whereas regions of the sequence of high aggregation propensity dominate the overall tendency to aggregate, regions with low intrinsic aggregation propensities exert significant control over the balance of the prefibrillar and fibrillar species formed, and therefore play a major role in determining the neurotoxicity of the Abeta peptide. Copyright 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20409489      PMCID: PMC2856165          DOI: 10.1016/j.bpj.2009.12.4320

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  37 in total

1.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

Authors:  C Nilsberth; A Westlind-Danielsson; C B Eckman; M M Condron; K Axelman; C Forsell; C Stenh; J Luthman; D B Teplow; S G Younkin; J Näslund; L Lannfelt
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

2.  Role of Escherichia coli curli operons in directing amyloid fiber formation.

Authors:  Matthew R Chapman; Lloyd S Robinson; Jerome S Pinkner; Robyn Roth; John Heuser; Marten Hammar; Staffan Normark; Scott J Hultgren
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

3.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

4.  A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.

Authors:  Aneta T Petkova; Yoshitaka Ishii; John J Balbach; Oleg N Antzutkin; Richard D Leapman; Frank Delaglio; Robert Tycko
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-12       Impact factor: 11.205

Review 5.  Prions as protein-based genetic elements.

Authors:  Susan M Uptain; Susan Lindquist
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

6.  Mutational analysis of the aggregation-prone and disaggregation-prone regions of acylphosphatase.

Authors:  Martino Calamai; Gian Gaetano Tartaglia; Michele Vendruscolo; Fabrizio Chiti; Christopher M Dobson
Journal:  J Mol Biol       Date:  2008-09-12       Impact factor: 5.469

7.  Nucleated conformational conversion and the replication of conformational information by a prion determinant.

Authors:  T R Serio; A G Cashikar; A S Kowal; G J Sawicki; J J Moslehi; L Serpell; M F Arnsdorf; S L Lindquist
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

Review 8.  Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.

Authors:  Michael J Volles; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

9.  Kinetic partitioning of protein folding and aggregation.

Authors:  Fabrizio Chiti; Niccolò Taddei; Fabiana Baroni; Cristina Capanni; Massimo Stefani; Giampietro Ramponi; Christopher M Dobson
Journal:  Nat Struct Biol       Date:  2002-02

10.  Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Authors:  J C Janssen; J A Beck; T A Campbell; A Dickinson; N C Fox; R J Harvey; H Houlden; M N Rossor; J Collinge
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

View more
  19 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 2.  Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases.

Authors:  Prajwal Ciryam; Rishika Kundra; Richard I Morimoto; Christopher M Dobson; Michele Vendruscolo
Journal:  Trends Pharmacol Sci       Date:  2015-01-27       Impact factor: 14.819

3.  Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils.

Authors:  Yinon Shafrir; Stewart R Durell; Andriy Anishkin; H Robert Guy
Journal:  Proteins       Date:  2010-12

4.  Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation.

Authors:  Christopher L Moore; Michael H Huang; Shauna A Robbennolt; Kellen R Voss; Benjamin Combs; T Chris Gamblin; Warren J Goux
Journal:  Biochemistry       Date:  2011-11-29       Impact factor: 3.162

Review 5.  Modeling the complex pathology of Alzheimer's disease in Drosophila.

Authors:  Pedro Fernandez-Funez; Lorena de Mena; Diego E Rincon-Limas
Journal:  Exp Neurol       Date:  2015-05-27       Impact factor: 5.330

6.  Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation.

Authors:  Beinan Liu; Aileen Moloney; Sarah Meehan; Kyle Morris; Sally E Thomas; Louise C Serpell; Robert Hider; Stefan J Marciniak; David A Lomas; Damian C Crowther
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

7.  Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila.

Authors:  Ina Caesar; Maria Jonson; K Peter R Nilsson; Stefan Thor; Per Hammarström
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

8.  Expression in drosophila of tandem amyloid β peptides provides insights into links between aggregation and neurotoxicity.

Authors:  Elena Speretta; Thomas R Jahn; Gian Gaetano Tartaglia; Giorgio Favrin; Teresa P Barros; Sara Imarisio; David A Lomas; Leila M Luheshi; Damian C Crowther; Christopher M Dobson
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

9.  Protein amyloids develop an intrinsic fluorescence signature during aggregation.

Authors:  Fiona T S Chan; Gabriele S Kaminski Schierle; Janet R Kumita; Carlos W Bertoncini; Christopher M Dobson; Clemens F Kaminski
Journal:  Analyst       Date:  2013-02-18       Impact factor: 4.616

10.  Neurotoxicity of prion peptides mimicking the central domain of the cellular prion protein.

Authors:  Silvia Vilches; Cristina Vergara; Oriol Nicolás; Gloria Sanclimens; Sandra Merino; Sonia Varón; Gerardo A Acosta; Fernando Albericio; Miriam Royo; José A Del Río; Rosalina Gavín
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.